Epirubicin is not a substitute for doxorubicin, and the toxicity and application of the two are different.
The therapeutic effect of epirubicin is relatively good, the toxicity to the heart is relatively small, usually feasible intubation as well as chemotherapy treatment, mainly used for the treatment of malignant lymphoma, breast cancer, lung cancer and a variety of other solid tumors. Doxorubicin should be taken under the guidance of a doctor to avoid self-medication, which may cause adverse side effects on health, pay attention to the adverse effects of the drug during the use of the drug, and consult a doctor in time if any abnormality occurs.
Doxorubicin can produce some toxicity to the heart of the body, and has potential mutagenic and carcinogenic effects in the human body, bone marrow suppression and cardiotoxicity are the two most important adverse reactions of doxorubicin.
Doxorubicin can treat acute leukemia, breast cancer, lung cancer, ovarian cancer, osteosarcoma and neuroblastoma, etc. Doxorubicin is contraindicated if there is fever infection, intestinal obstruction, jaundice and liver damage.
Therefore, epirubicin is not a substitute for doxorubicin. If you have any uncomfortable symptoms, it is recommended to go to the hospital in time for clear diagnosis and treatment.